Histamine inflammation responds to redox nutrients like vitamin C and glutathione, which stabilize mast cells and prevent degranulation. The speaker breaks histamine management into three phases: release, transport, and elimination, with different interventions for each. H1 and H2 blockers handle acute symptoms while flavonoids and redox support work upstream to stop release in the first place.
Beyond histamine metabolism, trying to just get it out of the body, turns out that redox support is very important for histamine and mast cell modulation, which we've all known clinically forever. And that's basically keeping a balance so that the membranes are less likely to degranulate and keeping a balance between vitamin C, glutathione, and tocopherols at the very base anyway of redox. It's a nice paper about inflammation and histamine release. I'll save you the time. Inflammation gives you more histamine release. There you go. We want to target histamine across its life cycle in the body if we really have a mast cell patient or somebody With a lot of histamine effect. So there's release, which is usually degranulation. There's transport, which mostly has to do with those metabolic pathways. Then there's binding and elimination, which also has to do with metabolic pathways. So we can intervene here if it's a significant emergency. You can give histamine-binding drugs, which work on the H1 and H2 receptors on the right. If you have a mast cell stabilizer like a flavonoid, that helps as well as redox support kind of on the left. And then all the metabolism is those 3 pathways and helping the histamine to leave.
